Waters LC Symposium - Biomedical Research
From the everyday consumer to scientists in the laboratory, we all rely on accurate information to make critical decisions.
Waters Corporation is pleased to bring together chromatography thought leaders for a week of scientific talks, live demonstrations, panel discussions, and networking regarding novel liquid chromatography technologies and applications.
Join us for this virtual symposium beginning with a plenary session on Monday, March 22nd and followed by application sessions for Pharma, Food, Materials and Biomedical Research throughout the week!
FRIDAY, MARCH 26, 2021
Morning Session Only - 5:00 - 6:30pm CET
ACQUITY PREMIER in Biomedical Research
The goal of any Biomolecular Research project is to find, identify, and quantify the relevant molecules that are critical in a biological process or condition. ACQUITY PREMIER technology helps us not miss the important, hard to see molecules that other technologies might tend to diminish or lose altogether. Any molecular discovery and subsequent translational project should benefit with a move to PREMIER technology.
Presentations:
1. Small Samples and Difficult Analytes: Maximizing Your Metabolite Profilies
Presenter: Professor Ian Wilson (Imperial College London)
Ian Wilson trained as a biochemist at the University of Manchester Institute of Science and Technology followed by a PhD in the Chemistry Dept. at Keele University. He spent much of his subsequent career in the Pharmaceutical industry, most recently as a Senior Principal Scientist in the Dept of Drug Metabolism and Pharmacokinetics at the AstraZeneca Research site at Alderley Park in Cheshire (UK). In September 2012 he joined Imperial College in London as Professor of Drug metabolism and Molecular Toxicology and remains a visiting Professor there. An analytical chemist by training he employs advanced instrumental analytical methods to generate data to enable biological systems to be better characterized and understood. His research interests cover a diverse range of topics including metabonomics/metabolomics, drug metabolism, toxicology, systems biology and the microbiome. A particular focus is currently the inter-dependence of the host and the gut microbiota in terms of the interplay between the effects of the host on the metabolism of the consortia of microbes that make up the gut microbiome and the effect of these organisms on the metabolism of the host. He is the author, or co-author, of over 550 papers or reviews, and has received a number of awards in separation and analytical science from the Royal Society of Chemistry, the Chromatographic Society and the Belgian Society for Pharmaceutical Sciences and the Bioanalysis Significant Contribution Award (BOSCA) from the journal “Bioanalysis”.
2. Maximizing Phosphopeptide Recovery in LC-MS Studies with ACQUITY PREMIER
Presenter: Lee Gethings, Ph.D. (Senior Manager, Biomedical Research, Waters Corporation)
Dr Gethings is currently the Senior Manager of Biomedical Research with responsibility for the OMICS scientific group within Waters. Primarily focused on LC-MS applications for both targeted and untargeted methodologies, with specialism predominantly on high resolution mass spectrometry, with significant contributions to data independent strategies and associated informatic pipelines. Prior to joining the company in 2006, he received his honors degree in Chemistry from the University of York (2002), Master’s degree from the University of Manchester, Institute of Science & Technology (2003) and gained a PhD in biological mass spectrometry (2008). His focus of research has long been associated with proteomics with an interest in systems biology, encompassing metabolomics and lipidomics. Over the period of 14 years within Waters, he has built a collaborative network globally working with a diverse set of academics contributing to multi-interdisciplinary projects. In additional to his industrial role, Dr Gethings also has an academic position at the University of Manchester within the Division of Immunity and Respiratory Medicine.
3. Panel Discussion
Moderated by: Roy Martin, Ph.D. (Sr. Manager, Biological Mass Spectrometry, Waters Corporation)
Dr. LeRoy B. Martin, III is a Senior Manager for Biological Mass Spectrometry at Waters Corporation. His primary role is developing and implementing advanced mass spectrometry solutions in the Americas. He is currently managing the Biomolecular Research marketing effort in the Americas. He is also charged with evaluating and integrating new technologies and planning for their inclusion either as Waters Corp. offerings or in combinations of instrumentation platforms. He’s particularly focused on the ion mobility, imaging, and direct analysis platforms and integrating these technologies into a molecular discovery platform.
